Milae Bioresources Co., Ltd. (KOSDAQ:218150)
South Korea
· Delayed Price · Currency is KRW 3,690.00
+35.00 (0.96%)
Last updated: Apr 1, 2025
Milae Bioresources Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Other Revenue | - | - | - | - | 0 | Upgrade
|
| Revenue | 62,453 | 60,016 | 75,635 | 66,668 | 47,497 | Upgrade
|
| Revenue Growth (YoY) | 4.06% | -20.65% | 13.45% | 40.36% | -5.16% | Upgrade
|
| Cost of Revenue | 54,554 | 51,911 | 66,210 | 58,308 | 40,821 | Upgrade
|
| Gross Profit | 7,900 | 8,105 | 9,425 | 8,361 | 6,676 | Upgrade
|
| Selling, General & Admin | 6,574 | 6,943 | 6,757 | 5,530 | 4,275 | Upgrade
|
| Research & Development | 545.24 | 534.89 | 521.61 | 461.83 | 504.36 | Upgrade
|
| Other Operating Expenses | 43.34 | 40.55 | 56.06 | 14.76 | 15.67 | Upgrade
|
| Operating Expenses | 7,716 | 8,084 | 7,842 | 6,506 | 5,517 | Upgrade
|
| Operating Income | 183.74 | 20.19 | 1,583 | 1,855 | 1,159 | Upgrade
|
| Interest Expense | -439.5 | -399.63 | -685.42 | -778.2 | -235.43 | Upgrade
|
| Interest & Investment Income | 731.35 | 1,008 | 366.78 | 116.75 | 135.58 | Upgrade
|
| Currency Exchange Gain (Loss) | -9.52 | -13.87 | -4.61 | 2.25 | -14.55 | Upgrade
|
| Other Non Operating Income (Expenses) | -114.25 | -12.44 | -63.6 | -16.15 | 41.12 | Upgrade
|
| EBT Excluding Unusual Items | 351.81 | 601.8 | 1,196 | 1,180 | 1,086 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 1.6 | -303.33 | -41.2 | -54.97 | Upgrade
|
| Gain (Loss) on Sale of Assets | 5.88 | 6.94 | 12.8 | 5.73 | 3.21 | Upgrade
|
| Asset Writedown | -875.01 | -356.45 | - | - | - | Upgrade
|
| Other Unusual Items | - | 139.06 | - | - | - | Upgrade
|
| Pretax Income | -517.31 | 392.95 | 905.4 | 1,144 | 1,034 | Upgrade
|
| Income Tax Expense | -97.58 | 33.74 | 27.25 | 65.28 | 81.11 | Upgrade
|
| Earnings From Continuing Operations | -419.73 | 359.21 | 878.15 | 1,079 | 953.2 | Upgrade
|
| Minority Interest in Earnings | -13.77 | 82.14 | 84.62 | 63.79 | -1.37 | Upgrade
|
| Net Income | -433.5 | 441.35 | 962.77 | 1,143 | 951.83 | Upgrade
|
| Net Income to Common | -433.5 | 441.35 | 962.77 | 1,143 | 951.83 | Upgrade
|
| Net Income Growth | - | -54.16% | -15.75% | 20.05% | -7.57% | Upgrade
|
| Shares Outstanding (Basic) | 20 | 19 | 19 | 18 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 19 | 19 | 18 | 18 | Upgrade
|
| Shares Change (YoY) | 2.69% | 2.63% | 5.51% | -0.06% | -0.13% | Upgrade
|
| EPS (Basic) | -22.00 | 23.00 | 51.50 | 64.49 | 53.68 | Upgrade
|
| EPS (Diluted) | -22.00 | 23.00 | 51.00 | 64.00 | 53.68 | Upgrade
|
| EPS Growth | - | -54.90% | -20.31% | 19.22% | -7.45% | Upgrade
|
| Free Cash Flow | -1,069 | 2,603 | 706.43 | 2,452 | 632.76 | Upgrade
|
| Free Cash Flow Per Share | -54.24 | 135.64 | 37.78 | 138.38 | 35.69 | Upgrade
|
| Gross Margin | 12.65% | 13.50% | 12.46% | 12.54% | 14.06% | Upgrade
|
| Operating Margin | 0.29% | 0.03% | 2.09% | 2.78% | 2.44% | Upgrade
|
| Profit Margin | -0.69% | 0.73% | 1.27% | 1.71% | 2.00% | Upgrade
|
| Free Cash Flow Margin | -1.71% | 4.34% | 0.93% | 3.68% | 1.33% | Upgrade
|
| EBITDA | 1,357 | 1,076 | 2,612 | 2,776 | 1,880 | Upgrade
|
| EBITDA Margin | 2.17% | 1.79% | 3.45% | 4.16% | 3.96% | Upgrade
|
| D&A For EBITDA | 1,173 | 1,056 | 1,029 | 920.77 | 720.23 | Upgrade
|
| EBIT | 183.74 | 20.19 | 1,583 | 1,855 | 1,159 | Upgrade
|
| EBIT Margin | 0.29% | 0.03% | 2.09% | 2.78% | 2.44% | Upgrade
|
| Effective Tax Rate | - | 8.59% | 3.01% | 5.71% | 7.84% | Upgrade
|
| Advertising Expenses | 331.9 | 515.17 | 418.44 | 106.4 | 8.68 | Upgrade
|
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.